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The impact of epilepsy on the quality of life of older people with epilepsy has rarely been investigated. As part of a large preva-
lence study of epilepsy conducted in one UK Health Region, we investigated the burden of their condition in older compared
with younger people. A second analysis compared quality of life in those men and women diagnosed after the age of retirement
from the workforce compared with those diagnosed before that age.
Data were collected from men and women with epilepsy and from their primary and secondary care physicians.
There were few differences between older and younger people with regard to their reported quality of life, though younger
people were more likely to report feeling stigmatized by their condition. Older people with epilepsy diagnosed in later life were
more anxious and depressed than those diagnosed earlier and their overall perception of quality of life was more likely to be
negative.
Our data emphasize that older people do not necessarily experience poorer quality of life than younger people, but those first
diagnosed in later life do appear to have a quality of life which is more impaired. Consideration should be paid to the important
psychosocial consequences of epilepsy in the older person.
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INTRODUCTION
Despite an awareness of the increase in the incidence
and prevalence of epilepsy after the age of 601–4, there
is relatively little documented about the impact of this
condition on the everyday lives of older people5.
Epidemiological studies have highlighted that
epilepsy is, however, the third most common neuro-
logical condition of older age, after cardiovascular ac-
cidents and dementia and subsequently represents a
significant health problem. According to Tallis6, the
occurrence of seizures may represent a ‘significant
watershed in an older person’s life after which there
is a sharp decline in functional independence’.
Earlier studies have shown that the clinical man-
ifestation of seizures in older people can be quite
different from those in younger patients, with pro-
longed postictal states and an increased incidence
of Todd’s phenomena especially postictal hemipare-
sis7, 8, often resulting in injuries which, because of
the ageing process, may also be more serious. A his-
tory of seizure activity is frequently inadequate and
distinguishing seizures from cardiovascular causes of
episodic loss of consciousness can be particularly dif-
ficult. Seizures are often symptomatic and more likely
due to underlying focal cerebral lesions, in particular
cerebrovascular disease9. Concurrent pathology unre-
lated to the seizures is common and the older person
with epilepsy will frequently be on medication addi-
tional to antiepileptic drugs (AEDs). The issue of the
side-effects of AED treatment on cognitive function-
ing in older people with epilepsy has yet to be sys-
tematically addressed although a decrease in cognitive
functioning associated with the ageing process may be
intensified by the effects of AEDs. A number of au-
thors have suggested that epilepsy in older people can
have both immediate and less immediate deleterious
consequences for quality of life (QOL). Loss of confi-
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dence, increased social isolation, poor self esteem and
increased levels of anxiety and depression have been
suggested as important contributions to reduced QOL
in older people with epilepsy6, 10, although to date evi-
dence is based on clinical anecdotal experience and no
formal QOL studies have been conducted to examine
these effects.
In order to determine the impact of epilepsy in
this group of patients we examined the data from a
large cross-sectional study of epilepsy in the commu-
nity11, 12. The overall aim of the community study was
to assess levels of disability and handicap in a popula-
tion of people of all ages with active epilepsy; and to
identify clinical, social and psychological factors asso-
ciated with them. The study also aimed to examine the
quality of primary and secondary care provided to peo-
ple with epilepsy. A QOL questionnaire, based on the
Liverpool QOL Battery13 and containing measures of
physical, social and psychological well-being as well
as information on clinical and demographic status, was
administered to 1180 adult subjects in the Mersey Re-
gion in the United Kingdom. The purpose of this paper
is to compare and contrast the QOL profile of older vs.
younger people with epilepsy. Definitions of ‘older’ in
previous studies are inconsistent14; for the purposes of
the present study, we have adopted a cut-off point of
60 years in women and 65 years in men, reflecting the
normal retirement age in the UK. An additional hy-
pothesis that we wished to explore was whether age
of onset of epilepsy is a critical variable determining
QOL of older people. Our supposition was that those
diagnosed prior to retirement from paid employment
would report a more severely compromised QOL than
those diagnosed later. A further comparison was there-
fore made between older people diagnosed after the
age of retirement from the work force and older peo-
ple diagnosed before that point in their working lives.
MATERIALS AND METHODS
Individuals within the study were drawn from a trawl
of the records of 31 general practitioners in the UK11.
General practices were randomly selected to be repre-
sentative of single-handed, small and large group prac-
tices and of urban, inner city and rural practices in
the Mersey region. Individuals were deemed as hav-
ing established epilepsy and so eligible to participate
in the study if they had had a seizure in the past 2 years
or were seizure-free but currently taking AEDs. Indi-
viduals participating in the study were identified from
the practice morbidity and repeat prescription regis-
ters. A hospital consultant confirmed a diagnosis of
epilepsy in 70% of the cases; in the remaining 30% a
diagnosis was made by the general practitioner. Of the
original 1190 adults identified from the general practi-
tioners’ records, 215 had learning disabilities or phys-
ical health problems severe enough to prevent them
from participating in the study or could not be traced
and so were excluded. Nine hundred and seventy-
five adults were therefore identified as eligible. For
those eligible to participate, clinical information about
their epilepsy was abstracted from the medical records
held by the general practices. Information was col-
lected on the first and most recent seizure, aetiology
of epilepsy, classification of seizure types and the pres-
ence of any health problems other than epilepsy (men-
tal or neurological handicap, psychiatric disorder and
other chronic medical disorder).
Postal questionnaires were then sent out to these
975 individuals asking them about their QOL and the
quality of services they received in respect of their
epilepsy. Six hundred and ninety-six adults (72% re-
sponse rate) returned a usable questionnaire; 27 of
whom were excluded from the present analysis be-
cause information was not available as to their age,
leaving 669 individuals who could be included. There
was no difference between the responders and non-
responders for current seizure activity (53% cf. 58%,
P = 0.08); there was also no difference for duration
of epilepsy (9 years in both groups); age of onset was
somewhat later in non-responders than in responders
(27 years cf. 22 years). A detailed description of dif-
ferences in the clinical and demographic characteris-
tics of responders, non-responders and those classed
as ineligible is provided elsewhere11.
Table 1: Contents of the QOL questionnaire.
Psychological
Physical domain Social domain domain
Seizure frequency11 Impact14 Anxiety16
Seizure severity28 Stigma18 Depression16
Seizure type11 Education/ Overall QOL20
employment status11
Injuries24 Marital status11
Side-effects15
The health-related QOL questionnaire
Each individual who participated in the study com-
pleted a questionnaire battery containing validated
measures of physical, social and psychological func-
tioning, various questions about their epilepsy and
questions relating to their demographic characteristics
(see Table 1).
Contents of the questionnaire
The impact of epilepsy scale and the adverse events
profile were specifically designed by the study team
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to be sensitive to the problems associated with the as-
sessment and treatment of epilepsy and its impact on
day to day functioning.
The Impact of Epilepsy scale is an 8-item scale
developed to assess the impact of epilepsy and
antiepileptic drug therapy on individuals’ relation-
ships with friends and family, social life, employment,
health, self-esteem, plans for the future and standard of
living. It is scored on a simple Likert scoring system.
This scale was designed specifically to assess the psy-
chosocial consequences of living with epilepsy and its
treatment. Acceptable levels of reliability and validity
of the scale have been reported elsewhere15.
The Adverse Drug Events Profile (AEP) is a 19-
item checklist developed to quantify patients’ percep-
tions of the side-effects of antiepileptic drug treatment.
It contains items relating to both CNS and non-CNS
dose-related side-effects. The profile has been shown
to be of good reliability, good construct and discrim-
inant validity16 and in a recent study, to discriminate
reliably between four standard AEDs. Patients often
complain about antiepileptic drugs and side-effects
and this scale reflects an important aspect of living
with epilepsy and its treatment.
The Hospital Anxiety and Depression scale (HAD)
is an established measure of patients’ perception of
their current level of psychological functioning. It
contains 14 items, seven relating to anxiety and seven
relating to depression. Scoring for each item is on a
0–3 scale. A score of 0–7 represents a non-case of
anxiety or depression, a score of 8–10 represents a
borderline case and a score of 11+ represents a clini-
cal case17. The Hospital Anxiety and Depression scale
has been shown to correlate highly with psychiatric
assessment18.
The Stigma scale is a 3-item scale adapted from a
measure originally designed to assess the perceived
stigma of a stroke and revised to make it applicable
to epilepsy19, 20. It has a simple scoring system of 0
or 1 for each item; a score of 3 represents the per-
ception of being severely stigmatized by the epilepsy.
Evidence of its reliability and validity has been well-
documented11, 19.
The Terrible–Delighted Faces, developed by An-
drews and Withey21 as a global QOL measure, was
used as a summary measure of respondents’ over-
all life quality. This is in line with the recommen-
dation that QOL assessments should include a sum-
mary measure as well as measures of individual QOL
domains22. Respondents were asked to say which of
seven facial expressions, ranging from terrible to de-
lighted, came closest to the way they felt about life as
a whole.
Demographic and epilepsy-related variables: Sin-
gle items were used to elicit information about current
education and employment status and marital/living
status. Information relating to seizure type, seizure
frequency, age of onset, duration of epilepsy, current
AED medication (type but not dose), and any seizure-
related injuries occurring in the past 12 months, was
also collected from patients participating in the study.
Patients were asked to categorize their seizures as:
major seizures only; major and other seizures; other
seizures only; and as occurring once or more per
month, less often than once a month, or not at all in
the last year (seizure-free).
Statistical analysis
In order to examine the relationship between the phys-
ical, social and psychological aspects of epilepsy and
older age we compared four groups: all men aged
<65 and all women aged <60 at the time of data
collection (Group 1); and all men aged 65+ and all
women aged 60+ (Group 2); all men aged 65+ at
the time of data collection and diagnosed before the
age of 65 and all women aged 60+ diagnosed be-
fore the age of 60 (Group 2a); and all men aged 65+
diagnosed at 65 or over and all women aged 60+ di-
agnosed at 60 or over (Group 2b). The cut-off points
selected represent the normal age of retirement from
paid employment for men and women in the UK. Data
from the questionnaire batteries were analysed using
the SPSSx statistical package23 on the University of
Newcastle network. Tests for significant associations
across the clinical and demographic characteristics
were completed using the chi-squared test for categor-
ical variables. Associations significant at the 5% level
and above are reported.
RESULTS
The analyses presented here are based on 669 adults
for whom information about age and gender was com-
plete. Of these, 324 were males (48%); median age
of the sample was 45 years and median age of onset
was 18 years. For the purposes of the analyses we de-
fined four groups: Group 1 comprised men aged <65
and women aged <60 at the point of data collection
(n = 514); Group 2 comprised men aged 65+ and
women aged 60+ (n = 155). Group 2 was further
subdivided into: Group 2a, which comprised men aged
65+ diagnosed before age 65 and women aged 60+
diagnosed before age 60 (n = 114); and Group 2b,
which comprised men aged 65+ diagnosed at age 65+
and women aged 60+ diagnosed at 60+ (n = 32).
Nine older people for whom information about age of
onset was missing are excluded from the comparison
between Groups 2a and 2b.
Younger adults with epilepsy (Group 1) were less
likely to be widowed and more likely to be single
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and in employment than older adults (Group 2) (see
Table 2 for marital status: χ2 = 158.70, df. = 3,
P < 0.01; for employment status χ2 = 79.42, df. =
1, P < 0.001). A very much higher proportion of
older adults lived alone (see Table 2). Younger adults
(Group 1) more often reported generalized seizures
than did older adults (Group 2) (58% compared to
34%—see Table 3: χ2 = 11.04, df. = 1, P < 0.001).
Table 2: Comparison of demographic characteristics for
Groups 1, 2, 2a and 2b.
Group Group Group Group
Variable 1 2 2a 2b
Gender: male (%) 51.6 38.1 40.4 34.4
Current age (yrs)* 38 70 69 74
Age at onset (yrs)* 16 49 39 65.5
Marital status (%)
Single 32.3 8.4 9.6 3.1
Married/cohabiting 57.2 60.0 59.6 62.5
Divorced/separated 9.3 1.9 1.8 3.1
Widowed 1.2 29.7 28.9 31.3
Living with spouse/steady 58.0 60.0 59.6 62.5
partner (%)
Living alone (%) 9.7 31.6 33.3 25.0
Employment status (%)
Employed full-time 35.5 3.3 4.4 0
Employed part-time 9.3 2.0 0.9 6.5
Unemployed 13.0 0 0 0
Retired 3.4 72.4 70.8 77.4
Permanent sick 19.5 2.0 2.7 0
Houseperson 13.6 19.1 19.5 16.1
Other 5.7 1.3 1.8 0
Median. Group 1 = All men aged <65 and all women aged <60,
Group 2 = All men aged 65+ and all women aged 60+, Group 2a
= All men aged 65+ diagnosed before age 65 and all women aged
60+ diagnosed before age 60, Group 2b = All men aged 65+
diagnosed at 65 or over and all women aged 60+ and diagnosed at
60 or over.
Table 3: Reported seizure types.
Group Group Group Group
Seizure type % 1 2 2a 2b
Generalized 58.3 33.9 35.9 27.3
Absence 46.2 46.0 40.9 53.8
Complex partial 31.3 38.1 43.2 38.5
Faints 29.1 25.4 22.7 30.8
Myoclonus 20.0 14.3 9.1 23.1
Other 18.9 11.1 9.1 7.7
Group 1 = All men aged <65 and all women aged <60, Group 2 =
All men aged 65+ and all women aged 60+, Group 2a = All men
aged 65+ diagnosed before age 65 and all women aged 60+
diagnosed before age 60, Group 2b = All men aged 65+ diagnosed
at 65 or over and all women aged 60+ and diagnosed at 60 or over.
Forty-seven percent of the respondents in Group 1
reported having been seizure-free in the last 12 months
compared with 60% of Group 2 (see Fig. 1; χ2 =
17.812, df. = 2, P < 0.001).
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Fig. 1: Reported seizure frequency (%s in each group report-
ing none in last year, less than 1 or 1+ per month).
Younger adults (Group 1) were more likely to re-
port all types of seizure-related injuries (apart from
other fractures) than were older adults, probably re-
flecting that they more often had generalized seizures
and were less likely to be seizure-free (Table 4: dif-
ferences were non-significant for all types of injury
except seizures while bathing/swimming (χ2 = 5.24,
df. = 1, P < 0.05)).
Table 4: Percentage of participants experiencing
seizure-related injuries in the last year.
% of sample
Group Group Group Group
Injuries 1 2 2a 2b
Burns/Scolds 17.4 9.4 12.8 0
Head injury 22.1 17.0 18.2 20.0
Dental injury 10.2 2.1 2.9 0
Other fracture 5.2 9.3 9.7 0
Seizure in bath/swimming 16.1 3.9 5.7 0
Group 1 = All men aged <65 and all women aged <60, Group 2 =
All men aged 65+ and all women aged 60+, Group 2a = All men
aged 65+ diagnosed before age 65 and all women aged 60+
diagnosed before age 60, Group 2b = All men aged 65+ diagnosed
at 65 or over and all women aged 60+ and diagnosed at 60 or over.
Ninety-five percent of respondents to the study re-
ported being on antiepileptic medication, the majority
receiving monotherapy (Group 1 = 66%, Group 2 =
75%, Group 2a = 66%, Group 2b = 94%). Around
a fifth in each group were prescribed carbamazepine;
older adults were more likely to be taking phenytoin
and younger adults were more likely to be taking val-
proate (see Table 5: χ2 = 38.30, df. = 4, P <
0.001). There were marked differences in the medi-
cation regimens of older people diagnosed pre- and
post-retirement (Groups 2a and 2b), the most notable
being in prescribing of phenytoin. The most common
complaints associated with AED treatment were CNS-
related side-effects, e.g. tiredness, sleepiness, nervous-
ness, difficulty in concentrating and memory prob-
lems (see Table 6). Older people (Group 2) were more
likely to report problems with unsteadiness (53% cf.
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25%: χ2 = 19.62, df. = 1, P < 0.001), upset stom-
ach (33% cf. 26%: χ2 = 5.60, df. = 1, P < 0.05),
dizziness (42% cf. 30%: χ2 = 3.79, df. = 1, P <
0.05) and disturbed sleep (50% cf. 37%: χ2 = 4.11,
df. = 1, P < 0.05), while younger people (Group 1)
were likely to report more problems with tiredness
(69% cf. 57%: χ2 = 3.72, df. = 1, P = 0.05),
feelings of aggression (35% cf. 17%: χ2 = 8.56,
df. = 1, P < 0.05) and skin problems (30% cf. 12%:
χ2 = 9.47, df. = 1, P < 0.01). A number of possible
explanations for these differences present themselves,
including the effects of age and different prescribing
practices. There were no significant differences in re-
ported side-effects for Groups 2a and 2b.
Table 5: Reported current AED medication.
% of Sample
Group Group Group Group
Type of medication 1 2 2a 2b
Carbamazepine 24.2 20.5 17.0 26.7
Phenytoin 17.9 35.1 29.5 53.3
Phenobarbitone 4.1 11.3 14.3 3.3
Sodium valproate 20.1 8.6 8.0 10.0
Other 33.7 24.5 31.3 6.7
Group 1 = All men aged <65 and all women aged <60, Group 2 =
All men aged 65+ and all women aged 60+, Group 2a = All men
aged 65+ diagnosed before age 65 and all women aged 60+
diagnosed before age 60, Group 2b = All men aged 65+ diagnosed
at 65 or over and all women aged 60+ and diagnosed at 60 or over.
There were no obvious differences between younger
and older adults for anxiety and depression. However,
older adults diagnosed post-retirement age were more
likely than those diagnosed pre-retirement to be both
mildly anxious and mildly or moderately depressed
(though the differences were not statistically signif-
icant: see Table 7). The majority of respondents re-
ported no feelings of stigma. Younger adults were
more likely than their older counterparts to report feel-
ing stigmatized by their condition (see Table 7: χ2 =
25.50, df. = 3, P < 0.01); in particular, younger peo-
ple were four times more likely to report feeling highly
stigmatized. There was no difference for stigma be-
tween the two older groups (Groups 2a and 2b).
An analysis of the responses to the impact of
epilepsy scale revealed that a significant number of
adults felt that their epilepsy and its treatment affected
aspects of their lives (see Table 8). In a comparison
of the responses given by younger and older adults,
the differences that emerged were all in the expected
direction and were statistically significant for relation-
ship with close family members (χ2 = 5.19, df. = 1,
P < 0.05), ability to work (χ2 = 35.24, df. = 1,
P < 0.001), nature of work (χ2 = 137.34, df. = 2,
P < 0.001), overall health (χ2 = 6.32, df. = 1,
P < 0.005) and for plans and ambitions (χ2 = 10.58,
df. = 1, P < 0.01). For example, younger people
were more likely to report an impact on employment
and plans for the future. In the comparison between
Groups 2a and 2b, none of the differences in reported
impact were statistically significant.
Table 6: Percentage of participants reporting side-effects of
medication always/often or sometimes in the last 4 weeks.
Percentage of participants reporting
side-effects
Adverse drug Group Group Group Group
event 1 2 2a 2b
Unsteadiness 25.5 53.0 44.2 62.5
Tiredness 69.4 57.4 57.8 56.3
Restlessness 34.5 38.2 33.3 56.3
Feelings of 35.1 16.7 14.0 25.0
aggression
Nervousness 44.1 44.9 46.7 41.2
and/or agitation
Headache 43.6 40.6 47.8 31.3
Problems with skin 29.6 11.6 8.9 11.8
Double or blurred 25.8 22.1 20.5 23.5
vision
Upset stomach 19.9 32.9 32.6 35.3
Difficulty in 49.8 42.9 45.7 41.2
concentrating
Trouble with 27.6 20.6 22.7 17.6
mouth or gums
Shaky hands 27.1 33.8 29.5 47.1
Weight gain 35.2 24.6 22.7 22.2
Dizziness 29.6 41.8 37.2 52.9
Sleepiness 46.9 42.6 40.9 47.1
Depression 44.0 33.3 32.6 37.5
Memory problems 53.4 63.8 66.7 64.7
Disturbed sleep 36.8 50.0 45.5 52.9
Group 1 = All men aged <65 and all women aged <60, Group 2 =
All men aged 65+ and all women aged 60+, Group 2a = All men
aged 65+ diagnosed before age 65 and all women aged 60+
diagnosed before age 60, Group 2b = All men aged 65+ diagnosed
at 65 or over and all women aged 60+ and diagnosed at 60 or over.
Table 7: Reported rates of anxiety and depression and
feelings of stigma.
Score Group Group Group Group
Scale 1 2 2a 2b
HAD Scale
Non-anxious 0–7 57.8 65.8 70.2 59.4
Mildly anxious 8–10 16.5 11.0 7.9 18.8
Moderately/ 11–21 25.7 23.2 21.9 21.9
severely anxious
Non-depressed 0–7 75.5 76.1 78.9 65.6
Mildly depressed 8–10 14.8 15.5 14.0 18.8
Moderately/ 11–21 9.7 8.4 7.0 15.6
severely depressed
Stigma Scale
No stigma 0 57.4 79.4 79.8 76.7
Mild stigma 1 21.3 13.5 13.5 13.3
Moderate stigma 2 7.3 4.3 3.8 6.7
Severe stigma 3 14.0 2.8 2.9 3.3
Group 1 = All men aged <65 and all women aged <60, Group 2 =
All men aged 65+ and all women aged 60+, Group 2a = All men
aged 65+ diagnosed before age 65 and all women aged 60+
diagnosed before age 60, Group 2b = All men aged 65+ diagnosed
at 65 or over and all women aged 60+ and diagnosed at 60 or over.
The quality of life of older people with epilepsy 97
Table 8: Percentages of participants assessing as ‘a
lot/some’ the impact of epilepsy on everyday life.
Percentage of participants reporting
impact on aspects of everyday life
Group Group Group Group
Epilepsy affects. . . 1 2 2a 2b
Relationship with partner 15.5 11.0 9.6 12.5
Relationship with close 25.1 15.7 12.4 21.9
family members
Social activities 33.5 25.7 27.4 19.4
Ability to work in paid 34.1 7.7 8.2 8.0
employment
Kind of work you can do 25.0 1.9 1.8 3.1
Overall health 39.3 28.0 27.7 27.6
Relationship with friends 22.5 19.5 18.0 23.3
Feelings of self 38.6 32.7 33.0 26.7
Plans and ambitions for the 37.6 23.1 25.2 17.2
future
Standard of living 29.0 26.5 25.7 30.0
Group 1 = All men aged <65 and all women aged <60, Group 2 =
All men aged 65+ and all women aged 60+, Group 2a = All men
aged 65+ diagnosed before age 65 and all women aged 60+
diagnosed before age 60, Group 2b = All men aged 65+ diagnosed
at 65 or over and all women aged 60+ and diagnosed at 60 or over.
Table 9: Percentage scores on the ‘Terrible–Delighted’ Faces
Scale.
Group Group Group Group
1 2 2a 2b
Ecstatic 18.6 20.5 22.3 12.9
Very happy 28.0 25.8 23.2 35.5
Happy 25.9 28.5 32.1 16.1
Neutral 14.5 11.9 9.8 19.4
Unhappy 8.0 8.6 8.0 12.9
Very unhappy 2.9 2.6 2.7 3.2
Devastated 2.0 2.0 1.8 0
Group 1 = All men aged <65 and all women aged <60, Group 2 =
All men aged 65+ and all women aged 60+, Group 2a = All men
aged 65+ diagnosed before age 65 and all women aged 60+
diagnosed before age 60, Group 2b = All men aged 65+ diagnosed
at 65 or over and all women aged 60+ and diagnosed at 60 or over.
Most of the respondents reported themselves as sat-
isfied with their QOL (Table 9). However, compared
with those diagnosed earlier, older people diagnosed
post-retirement more often indicated that either a neu-
tral or negative ‘face’ best represented their overall
QOL (χ2 = 13.05, df. = 4, P < 0.05).
DISCUSSION
To our knowledge, this study represents one of the
few attempts to examine the impact of epilepsy on the
physical, social and psychological well-being of older
people with epilepsy, in the context of a large cross-
sectional study of an unselected sample of adults with
this chronic condition. It also provided an opportunity
to consider whether there was any significant differ-
ence in the degree of the impact of epilepsy on older
people, depending on when the diagnosis was made.
Some important clinical differences were noted be-
tween the younger and older adults, the former being
more likely to be experiencing generalized seizures
that were less well controlled. Perhaps as a result of
these differences in the clinical characteristics of their
condition, younger adults were more likely to report
seizure-related injuries. This finding is at odds with
the belief that seizure-related injuries will be more fre-
quent in older people, as a consequence of their in-
creasing frailty. However, it should be noted that there
were relatively few old older people in this sample.
Of those defined as ‘older’, 75% were aged under 75
and only three were aged 85 or more. Furthermore, we
would urge caution in the interpretation of the findings
presented in Table 4, as the numbers of respondents in
Group 2b was small. It should be noted that in an ear-
lier analysis, we showed that another important pre-
dictor of seizure-related injury was gender24—in par-
ticular, women were found to be twice as likely as men
to experience burns and scalds, probably as a result of
their increased involvement in domestic activities.
The pattern of AED prescribing differed across the
groups, older patients being more likely to be tak-
ing the older AEDs. Among older people, those di-
agnosed as having epilepsy post-retirement were sig-
nificantly more likely than those diagnosed earlier to
be prescribed phenytoin, a finding which may reflect
that they were more often treated at the time of on-
set by non-specialist geriatricians. The incidence of
perceived AED side-effects was relatively high, and
the reporting of specific side-effects differed by age.
Older people more often reported unsteadiness and
dizziness, upset stomach, disturbed sleep and mem-
ory problems. In contrast, younger people more often
reported tiredness, feelings of aggression, problems
with skin, weight gain and depression. A number of
possible explanations for the differential reporting of
side-effects can be suggested, including that they re-
flect the different prescribing patterns previously high-
lighted. Alternatively, they may simply reflect differ-
ent age-related experiences of health and well-being.
There was consistent high reporting of memory prob-
lems across all the groups, which may reflect the con-
cerns people with epilepsy have about their memory
functioning—even though the evidence to date sug-
gests that the main cause of memory problems are
likely to be related to the underlying lesion and seizure
activity, rather than the AEDs themselves25. There was
no evidence that older people with epilepsy have lower
levels psychological well-being than do younger peo-
ple. However, older people with a later age of onset
were at increased risk of anxiety and depression and
more likely to assess their QOL overall either neu-
trally or negatively, compared to older people in whom
a diagnosis had been made earlier, possibly reflect-
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ing that they had had less time to adjust to the onset
of a chronic health problem and any associated limi-
tations and loss of independence. In contrast, though
there were no differences for stigma between the two
older groups, older people as a whole were less likely
to report feeling stigmatized than were younger peo-
ple. This is consistent with our finding that younger
people reported a greater impact of epilepsy on em-
ployment and ambitions for the future.
Our finding that rates of anxiety and depression
were similar in older and younger people with epilepsy
is consistent with reports from elsewhere: for example
the proportions of people regarded as a case of psy-
chiatric morbidity, as measured by the General Health
Questionnaire (GHQ-30), were similar across all ages,
rising only among the old older (75 plus)26. Though
we are unable to locate parallel figures for anxiety,
prevalence studies in Europe and the UK report figures
of around 10–13% for moderate to severe depression
in older people, and 20–22% when the less severe cat-
egories are included27. Thus, the rates of depression
reported by our sample of older people with epilepsy
do not seem significantly higher than those for age-
equivalent non-epileptic populations.
There are a number of limitations to the study from
which the data reported here were drawn, which have
been previously addressed11, 12. Two important issues
not considered in this analysis were the effects of los-
ing a driving licence and the effects of losing employ-
ment as a result of a diagnosis of epilepsy and the po-
tential impact of both these for loss of independence.
The majority of older people, however, are unlikely
to be in employment and consequently the impact of
epilepsy in this area may be minimal. However, the
loss of a driving licence has potentially much more
serious consequences for independence. Older people
are more likely to live alone and have limited social
support, and if they are living with someone, they are
more likely to be providing informal care. Our analy-
sis has focused on QOL differences by age. However,
as pointed out earlier, there were very few very old
people in our sample. Further, there may also be im-
portant within-age group differences by gender which
the present analysis has ignored. Future research could
helpfully address these limitations in greater depth.
A further limitation of our research is our reliance
on a previously specified battery of measures to as-
sess the impact of epilepsy on QOL in older people.
We would strongly recommend that any future stud-
ies should include qualitative research to ensure that
the issues identified by older men and women thus af-
fected are reflected in the measures chosen. However,
just as generic QOL measures are seen as having the
advantage over condition-specific ones that they allow
for cross-condition comparisons, so our measure may
be seen as having the advantage over an age-specific
one that it has allowed comparisons to be made across
different age groups of people with epilepsy.
In conclusion, it has been previously suggested that
because of uncertainty about the diagnosis and unpre-
dictability of its course, older people with epilepsy
may experience a marked loss of functional indepen-
dence and an accompanying decrease in aspects of
their QOL6. Our results do not support the notion of
an increased impact of epilepsy in older age per se, but
that time of diagnosis is crucial. Where the diagnosis
is made post-retirement, our data suggest an increased
risk of perceived impact and psychological impair-
ment. Further research is required to disentangle the
various possible explanations for this difference. What
is without dispute, however, is that the management
of this chronic condition in older as in younger peo-
ple should not only address its clinical treatment but
should also aim to alleviate its psychosocial impact.
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